If you had looked at WH Group on 1 January 2026 and decided to pass after reading the split between bullish automation hopes and bearish plant protein worries, the outcome so far would have been stark. Investors who held WH Group from the start of the year are down 22.3%, including dividends. With fresh records at Smithfield and a lobbying controversy now in the headlines, which early assumptions about volume, margins or regulatory risk would you test first?
If the move has made WH Group harder to judge, start where the gap is still open and scan 195 high quality undervalued stocks.
The Two WH Group Stories Investors Had To Weigh
The shares cost HK$8.67 at the start of the period, and WH Group sat between two very different but plausible stories about where profits might head next.
The bullish view saw a Fair Value of HK$9.13, a price implied by assumptions that revenue would shift by 0.7% a year and profit margin would settle near 5.0% on the back of China expansion and automation.
The cautious narrative pointed to a Fair Value of HK$6.9, built on worries that rising plant protein trends and regulatory costs would steadily erode margins and long term pork demand.
What The Evidence Around WH Group Actually Tested
Record Q1 operating profits at Smithfield lent some support to the optimistic WH Group story that packaged meats and vertical integration could underpin earnings. Yet the H1 2026 numbers told a tougher tale. Revenue moved to US$13,827m while net income slipped to US$770m and net margin edged down from 5.9% to 5.6%. The evidence cut both ways.
The Farm Bill lobbying disclosure issue adds a different test for you. The lesson is clear. When a thesis leans on regulatory comfort or brand trust, it may help to track margin trends and disclosure quality together, not just the headline profit line.
What WH Group’s Lower Price Is Really Asking You
Today WH Group trades at HK$6.29, after a share price that is down 22.3% from the start of the year. The selected Narrative’s Fair Value sits above the current price, anchored on packaged meats doing more of the heavy lifting.
The argument leans on premium products, new China channels and low cost pork inventories cushioning weaker hog and fresh pork cycles. For that higher figure to be reached, a buyer today would need to assume packaged meats keep growing fast enough to offset pressure in more volatile pork markets.
"The continued shift in WH Group’s earnings mix toward packaged meats, which already account for just over half of revenue and close to 90% of operating profit in 1H26, gives the company more exposure to higher-margin products that can support group net margins and earnings quality. The ongoing expansion of new and specialty channels in China, with these outlets already around 23 to 24% of packaged meat volume and growing roughly 43 to 50% year over year in early 2026, is expected to lift packaged meat revenue and help offset softer demand in traditional channels."
The price and this Narrative do not agree. → Uncover what this Narrative says WH Group is actually worth
Before The Next Story Makes Headlines
This company's disappointment is already part of the story. Your next idea could come from looking where the price and the possibilities still seem far apart. Here are three companies priced below our estimates.
- Company 1 - 26% below our estimate - targets repeat users of an injectable bone graft as indications expand and coverage improves.
- Company 2 - 33% below our estimate - extends a broad nutrition portfolio into more export channels while adding plant-based and specialty offerings.
- Company 3 - 31% below our estimate - wins additional subsea awards bundling quicker tieback projects with multiyear services and maintenance work.
Those are three of them. See the full list of 207 financially solid companies →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com